Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach
- Status
- COMPLETED
- Phase
- PHASE2
An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)
- Status
- UNKNOWN
- Phase
- PHASE2
Intense Airway Eosinophilia in Asthma
- Status
- COMPLETED
- Phase
- N/A
Characteristics of Patients With Type 2 Diabetes Mellitus (CVD-RNDR)
- Status
- COMPLETED
- Phase
- N/A
A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)
- Status
- COMPLETED
- Phase
- PHASE2
Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium
- Status
- TERMINATED
- Phase
- PHASE1
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
AZD6738 & Gemcitabine as Combination Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE3